Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?
A leap forward in standardizing the regenerative medicine supply chain
Date: November 15-17, 2023
Location: Palma, Spain
Date: December 9-12, 2023
Location: San Diego, CA
In the dynamic and ever-evolving realm of regenerative medicine and advanced therapies, the reliability of your supply chain could be the difference between success and failure. As the biopharmaceutical industry pushes the boundaries of science and innovation, the need for planning ahead becomes increasingly evident to ensure seamless operations and to uphold compliance with stringent industry standards.
For over 10 years, Cryoport Systems has been utilizing our near real-time condition monitoring solution that offers precise location information on shipments. With such vast experience, we’ve used our industry knowledge and superior technology to create solutions that encompass entire monitoring capabilities to provide full chain-of-custody and chain-of-condition data for our shipments.
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC